Treatment considerations in early rheumatoid arthritis.
作者信息
Schattner A
出版信息
J Intern Med. 1997 Jun;241(6):445-9. doi: 10.1111/j.1365-2796.1997.tb00001.x.
Abstract
摘要
相似文献
1
Treatment considerations in early rheumatoid arthritis.
J Intern Med. 1997 Jun;241(6):445-9. doi: 10.1111/j.1365-2796.1997.tb00001.x.
2
The combination of methotrexate, sulfasalazine and hydroxychloroquine is highly effective in rheumatoid arthritis.
Clin Exp Rheumatol. 1999 Jan-Feb;17(1):39-40.
3
Combination DMARD therapy with hydroxychloroquine, sulfasalazine, and methotrexate.
Clin Exp Rheumatol. 1999 Nov-Dec;17(6 Suppl 18):S53-8.
4
Changing sulphasalazine to methotrexate does not improve the 2-year outcomes of the initial single DMARD treatment in early rheumatoid arthritis: subanalysis of the FIN-RACo trial.
Ann Rheum Dis. 2013 May;72(5):786-8. doi: 10.1136/annrheumdis-2012-202737. Epub 2013 Jan 24.
5
Treatment of rheumatoid arthritis.
N Engl J Med. 1996 Sep 12;335(11):821-2; author reply 822-3.
6
[Evidence-based treatment of methotrexate-resistant rheumatoid arthritis. Combinations of conventional disease-modifying antirheumatic agents].
Dtsch Med Wochenschr. 2003 Jan 24;128(4):147-9. doi: 10.1055/s-2003-36869.
7
Treatment of rheumatoid arthritis with methotrexate alone, sulfasalazine and hydroxychloroquine, or a combination of all three medications.
N Engl J Med. 1996 May 16;334(20):1287-91. doi: 10.1056/NEJM199605163342002.
8
Treatment of rheumatoid arthritis.
N Engl J Med. 1996 Sep 12;335(11):822; author reply 822-3.
9
Rheumatoid arthritis.
Clin Evid. 2003 Jun(9):1349-71.
10
Improving patient-centred care for rheumatoid arthritis.
CMAJ. 2016 Oct 4;188(14):999-1000. doi: 10.1503/cmaj.160051. Epub 2016 Jun 27.
Zotero 插件